Literature DB >> 23834069

Eye tracking communication devices in amyotrophic lateral sclerosis: impact on disability and quality of life.

Marco Caligari1, Marco Godi, Simone Guglielmetti, Franco Franchignoni, Antonio Nardone.   

Abstract

People with amyotrophic lateral sclerosis (PwALS) show progressive loss of voluntary muscle strength. In advanced disease, motor and phonatory impairments seriously hinder the patient's interpersonal communication. High-tech devices such as eye tracking communication devices (ETCDs) are used to aid communication in the later stages of ALS. We sought to evaluate the effect of ETCDs on patient disability, quality of life (QoL), and user satisfaction, in a group of 35 regular ETCD users in late-stage ALS with tetraplegia and anarthria. The following scales were administered: 1) the Individually Prioritized Problem Assessment (IPPA) scale, in three conditions: without device, with ETCD and, when applicable, with an Eye Transfer (ETRAN) board; 2) the Psychosocial Impact of Assistive Devices Scale (PIADS); and 3) the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0). With ETRAN, IPPA showed an increase in communicative abilities with respect to the condition without device, but ETCD produced a further significant increase. PIADS evidenced a large increase of QoL, and QUEST 2.0 showed high user satisfaction with ETCD use. In conclusion, ETCDs should be considered in late-stage ALS with tetraplegia and anarthria, since in these patients they can reduce communication disability and improve QoL.

Entities:  

Mesh:

Year:  2013        PMID: 23834069     DOI: 10.3109/21678421.2013.803576

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  30 in total

1.  Eye-tracking computer systems for inpatients with tetraplegia: findings from a feasibility study.

Authors:  J J van Middendorp; F Watkins; C Park; H Landymore
Journal:  Spinal Cord       Date:  2014-12-02       Impact factor: 2.772

Review 2.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

3.  Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis.

Authors:  Meredith Bock; Y-Nhy Duong; Anthony Kim; Isabel Allen; Jennifer Murphy; Catherine Lomen-Hoerth
Journal:  Neurol Clin Pract       Date:  2017-12

Review 4.  Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis.

Authors:  Maria Elena Cicardi; Lara Marrone; Mimoun Azzouz; Davide Trotti
Journal:  EMBO J       Date:  2021-03-31       Impact factor: 11.598

5.  Users' satisfaction with assistive devices in South Korea.

Authors:  Sang-Heon Lee
Journal:  J Phys Ther Sci       Date:  2014-04-23

6.  Fully Implanted Brain-Computer Interface in a Locked-In Patient with ALS.

Authors:  Mariska J Vansteensel; Elmar G M Pels; Erik J Aarnoutse; Martin G Bleichner; Mariana P Branco; Timothy Denison; Zachary V Freudenburg; Peter Gosselaar; Sacha Leinders; Thomas H Ottens; Max A Van Den Boom; Peter C Van Rijen; Nick F Ramsey
Journal:  N Engl J Med       Date:  2016-11-12       Impact factor: 91.245

Review 7.  Selective Neuron Vulnerability in Common and Rare Diseases-Mitochondria in the Focus.

Authors:  Thomas Paß; Rudolf J Wiesner; David Pla-Martín
Journal:  Front Mol Biosci       Date:  2021-06-30

8.  Comparison of eye tracking, electrooculography and an auditory brain-computer interface for binary communication: a case study with a participant in the locked-in state.

Authors:  Ivo Käthner; Andrea Kübler; Sebastian Halder
Journal:  J Neuroeng Rehabil       Date:  2015-09-04       Impact factor: 4.262

9.  Eye gaze performance for children with severe physical impairments using gaze-based assistive technology-A longitudinal study.

Authors:  Maria Borgestig; Jan Sandqvist; Richard Parsons; Torbjörn Falkmer; Helena Hemmingsson
Journal:  Assist Technol       Date:  2016

10.  Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS.

Authors:  Ilary Allodi; Laura Comley; Susanne Nichterwitz; Monica Nizzardo; Chiara Simone; Julio Aguila Benitez; Ming Cao; Stefania Corti; Eva Hedlund
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.